Pharmaceutical

MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells

CHICAGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company...

Fresenius Leads New EASYGEN Consortium Aimed at Decentralizing CAR-T Cell Therapy and Improving Hospital Workflows

Physicians, researchers, and partner institutions across Europe aim to deliver innovative, personalized therapies more quickly Development project focused on a...

Ease Expands Its Online Veterinary Behavior Solution, Offering Pet Parents Expert Treatment for Pet Stress, Anxiety and Behavior Problems in the Comfort of Home

With veterinary clinic partners across 34 states, Ease is building the first centralized platform for veterinary behavioral medicine while keeping...

error: Content is protected !!